Status:
COMPLETED
A Study of LY3025876 in Healthy Volunteers
Lead Sponsor:
Eli Lilly and Company
Conditions:
Healthy Volunteers
Eligibility:
All Genders
21-65 years
Phase:
PHASE1
Brief Summary
This trial is conducted in Singapore. The aim of this trial is to evaluate the safety and tolerability of the study drug in healthy people and investigate how much of the study drug gets into the bloo...
Eligibility Criteria
Inclusion
- Must be either a healthy male or a healthy female who cannot become pregnant
- Have a body mass index (BMI) of 18.5 to 40.0 kilograms per meter squared (kg/m\^2), inclusive, at screening
Exclusion
- Are allergic to LY3025876 or related compounds
- Have a history of significant disease that may affect the actions of drugs or may pose a risk when taking the study medication
- Have a history of developing allergies, asthma, severe drug allergies (symptoms including, but not limited to, itching, red rashes, sores on the skin, scaling and shedding of skin), allergies or reactions to more than one drug, or have had bad reactions to skin creams containing corticosteroids. Corticosteroids are mainly used to control inflammation.
Key Trial Info
Start Date :
February 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT01528124
Start Date
February 1 2012
End Date
May 1 2012
Last Update
July 16 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Singapore, Singapore, 117597